Artivion Inc
AORT - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$981.01M
Close$
$-6.68
133.1% downside
Current Fair Value
133.1% downsideOvervalued by 133.1% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $981.01 Million |
|---|---|
| Enterprise Value | $1.34 Billion |
| Earnings per Share | $0.22 |
| Beta | 1.22 |
| Outstanding Shares | 48,541,000 |
Return
| Return on Equity | -3.94% |
|---|---|
| Return on Assets | -1.69% |
| Return on Invested Capital | 1.15% |
Valuation & Multiples
| P/E Ratio | -378.86 |
|---|---|
| PEG | 170.73 |
| Price to Sales | 2.25 |
| Price to Book Ratio | 2.25 |
| Enterprise Value to Revenue | 2.78 |
| Enterprise Value to EBIT | 120.48 |
| Enterprise Value to Net Income | -77 |
| Total Debt to Enterprise | 0.3 |
| Debt to Equity | 0.91 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 5, 2026
EPS Estimate
$-0.06
Consensus analyst estimateRevenue Estimate
$120.97 M
Consensus analyst estimateNext Earnings Call
Expected Date
February 11, 2027
EPS Estimate
$0.13
Consensus analyst estimateRevenue Estimate
$128.72 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Artivion Inc
1,200 employees
CEO: James Mackin
Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. Cr...